SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-055873
Filing Date
2023-07-10
Accepted
2023-07-10 17:12:58
Documents
15
Period of Report
2023-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181547-8k425_phoenix.htm   iXBRL 8-K 48304
2 SECOND AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PHO ea181547ex3-1_phoenix.htm EX-3.1 15345
3 AMENDMENT NO. 2 TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED JULY 7, 2023 ea181547ex10-1_phoenix.htm EX-10.1 19895
  Complete submission text file 0001213900-23-055873.txt   328594

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pbax-20230707.xsd EX-101.SCH 4142
5 XBRL DEFINITION FILE pbax-20230707_def.xml EX-101.DEF 27296
6 XBRL LABEL FILE pbax-20230707_lab.xml EX-101.LAB 37791
7 XBRL PRESENTATION FILE pbax-20230707_pre.xml EX-101.PRE 25916
9 EXTRACTED XBRL INSTANCE DOCUMENT ea181547-8k425_phoenix_htm.xml XML 7181
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 231080546
SIC: 2836 Biological Products, (No Diagnostic Substances)